Immediate Impact
2 by Nobel laureates 53 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Works of D. Perner being referenced
Serum microRNA ‐122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy
2013
Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| D. Perner | 352 | 312 | 108 | 22 | 386 | |
| Mohamed Eltabbakh | 292 | 279 | 61 | 21 | 402 | |
| Nami Mori | 316 | 321 | 64 | 31 | 438 | |
| Neiva Sellan Lopes Gonçales | 283 | 274 | 94 | 28 | 402 | |
| Xin Huang | 345 | 296 | 168 | 25 | 411 | |
| Ting‐Tsung Chang | 311 | 254 | 59 | 19 | 428 | |
| Marzia Margotti | 315 | 310 | 78 | 19 | 436 | |
| J. Albrecht | 380 | 357 | 63 | 17 | 433 | |
| Carmine Minichini | 263 | 269 | 117 | 35 | 439 | |
| M. Willems | 254 | 210 | 35 | 12 | 347 | |
| Cathy Schechterly | 189 | 117 | 81 | 12 | 344 |
All Works
Loading papers...